Blackstone has closed its latest fund – the $6.3bn BXLS VI – saying it is the largest ever private fund for the life sciences sector.

Merck’s drug enlicitide beat a handful of commonly used cholesterol-lowering drugs in a comparator trial, inching it closer to becoming the first oral PCSK9 inhibitor.

During this year’s American Academy of Dermatology annual meeting in Denver, companies like Sanofi, Biogen and Tanabe Pharma presented data for their respective candidates. But

Attempts by the White House to curry industry support for legislation that would codify last year’s voluntary drug pricing deals are being ignored by some

Two decades ago, when I was a baby-faced Capitol Hill reporter, Texas Republican Michael Burgess was a relatively new member of Congress, swept in with